Hannah Street
Psychiatry · Murfreesboro, TNNPI 1730773862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,900 and has fallen 57.0% since, to $1,247 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$970
- Otsuka America Pharmaceutical, Inc.$892
- Axsome Therapeutics, Inc.$854
- Corium, LLC$705
- Alkermes, Inc.$597
- plus $3K from 19 others
What the payments were for
- Food & beverage$8,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,312 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $970 |
| Otsuka America Pharmaceutical, Inc. | 44 | $892 |
| Axsome Therapeutics, Inc. | 30 | $854 |
| Corium, LLC | 36 | $705 |
| Alkermes, Inc. | 23 | $597 |
| Johnson & Johnson | 28 | $542 |
| Neurocrine Biosciences, Inc. | 17 | $458 |
| Ironshore Pharmaceuticals Inc. | 32 | $430 |
| Vanda Pharmaceuticals Inc. | 13 | $304 |
| Teva Pharmaceuticals USA, Inc. | 5 | $273 |
| Tris Pharma Inc | 7 | $123 |
| Sunovion Pharmaceuticals Inc. | 12 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $113 |
| Lundbeck LLC | 4 | $80 |
| Janssen Scientific Affairs, LLC | 1 | $78 |
| Supernus Pharmaceuticals, Inc. | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| Indivior Inc. | 4 | $65 |
| Neos Therapeutics, LP | 3 | $57 |
| Bausch Health US, LLC | 2 | $35 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,228 in reported general payments places this provider in the 90th percentile of 503 psychiatry providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 13 | $689 |
| Duloxetine Hcl | 11 | $333 |
| Clonazepam | 15 | $123 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Murfreesboro
- Samuel OkpakuMurfreesboro$7K
- Ravi SinghMurfreesboro$6K
- Rakesh AminNashville$3M
- Brian BonfardinJohnson City$2.6M
- John FenleyJohnson City$1.4M
- David SnowMaryville$605K
- Karthi NamasivayamKnoxville$225K
- Robert JamiesonNashville$141K
- George BrownJohnson City$91K
- Sricharan MoturiFranklin$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.